What is the place of β-blockade in patients who have experienced a myocardial infarction with preserved left ventricular function? Evidence and (Mis)interpretation

Progress in Cardiovascular Diseases

Volumn 44, Issue 4, 2002, Pages 243-250

  Freemantle, Nick ^a,b   Urdahl, Hege ^a,b   Eastaugh, Joanne ^a,b   Hobbs, F D Richard ^a,b,c  

^a School of Medicine   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ACETYLSALICYLIC ACID; ALPRENOLOL; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LABETALOL; METOPROLOL; OXPRENOLOL; PINDOLOL; PRACTOLOL; PROPRANOLOL; SOTALOL; TIMOLOL; XAMOTEROL;

BETA ADRENERGIC RECEPTOR BLOCKING; CONFIDENCE INTERVAL; DOSE TIME EFFECT RELATION; DRUG CHOICE; DRUG EFFICACY; DRUG MECHANISM; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; PATHOPHYSIOLOGY; REVIEW; STATISTICAL MODEL; SURVIVAL;

EID: 0036224445     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1053/pcad.2002.31586     Document Type: Article

References (19)

1. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute MI: ISIS1
2. Intravenous β-blockade in acute myocardial infarction: Should be used in combination with thrombolysis
3. What is the current place of β-blockade in secondary prevention after myocardial infarction? A systematic overview and meta regression analysis
4. The evidence for beta-blockers equals that for ACE inhibitors in heart failure
5. Evidence based clinical practice guideline: Aspirin for the secondary prophylaxis of vascular disease in primary care
6. Evidence based clinical practice guideline: Angiotensin converting inhibitors in the primary care management of adults with symptomatic heart failure
7. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
8. Bayesian approaches to random-effects meta-analysis: A comparative study
9. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
10. Absence of evidence is failure of research policy
11. Beta-blockers in heart failure
12. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
13. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
14. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
15. Large trials vs meta-analysis of smaller trials. How do their results compare?
16. Issues in comparisons between meta-analyses and large trials
17. Who do we need some large, simple randomised trials?